CTSO
Cytosorbents Corp
NASDAQ · Healthcare · Medical - Devices · US
$5.75
−0.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 9.83x
- P/S forward
- 0.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -24.06x
- Price / sales
- 0.49x
- Price / cash flow
- -1.75x
Enterprise value
- Enterprise value
- $40.0M
- EV / sales
- 1.07x
- EV / EBITDA
- -2.83x
- EV / EBIT
- -3.22x
- Market cap
- $18.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026